| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 152,109 | 139,911 | 130,970 | 155,510 | | Cost of Revenue | 102,921 | 98,634 | 98,970 | 109,930 | | | Gross Profit | 49,188 | 41,277 | 32,000 | 45,580 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,573 | 30,977 | 29,241 | 38,512 | | Non Recurring | 1,557 | 1,072 | 22,704 | 1,081 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,058 | 9,228 | (19,945) | 5,987 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 244 | (581) | (127) | 152 | | Earnings Before Interest And Taxes | 13,302 | 8,647 | (20,072) | 6,139 | | Interest Expense | 935 | 1,655 | 1,398 | 1,761 | | Income Before Tax | 12,367 | 6,992 | (21,470) | 4,378 | | Income Tax Expense | 3,980 | 1,228 | (3,251) | 908 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,387 | 5,764 | (18,219) | 3,470 | | | Non-recurring Events | | Discontinued Operations | 1,395 | (87) | (6) | (1,321) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,782 | 5,677 | (18,225) | 2,149 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,782 | $5,677 | ($18,225) | $2,149 |
|
0.22% Nasdaq 
Income Statement
